外照射放疗姑息治疗症状性骨转移:ASTRO临床实践指南
美国放射肿瘤学会(ASTRO)组建工作组,针对症状性骨转移的姑息外照射放疗提出5个关键问题,基于系统综述采用预设共识方法制定推荐并评估证据质量与推荐强度。推荐涵盖骨转移疼痛及脊柱转移伴或不伴脊髓/马尾压迫的放疗、术后放疗、地塞米松使用、常用分次方案、再程放疗及立体定向体部放疗的选择。
要点
- 推荐姑息放疗用于骨转移疼痛及脊柱转移伴或不伴脊髓/马尾压迫的止痛治疗。
- 脊柱转移致脊髓/马尾压迫者条件性推荐手术+术后放疗优于单纯放疗,并推荐使用地塞米松。
- 症状性骨转移常规放疗推荐800 cGy/1次、2000 cGy/5次、2400 cGy/6次或3000 cGy/10次。
核心结论
- 基于已发表数据,ASTRO工作组的推荐为症状性骨转移的姑息放疗提供了最佳临床实践指导。
研究设计与样本
- ASTRO组建工作组,针对症状性骨转移姑息放疗的5个关键问题,基于美国卫生研究与质量局(AHRQ)的系统综述,采用预设共识构建方法制定推荐,并评估证据质量和推荐强度。
主要发现
- 推荐姑息放疗用于骨转移疼痛及脊柱转移伴或不伴脊髓/马尾压迫的止痛治疗。
- 脊柱转移致脊髓/马尾压迫者,条件性推荐手术+术后放疗优于单纯放疗;并推荐使用地塞米松。
- 非脊柱骨转移需手术者,推荐术后放疗。
- 症状性骨转移常规放疗推荐800 cGy/1次、2000 cGy/5次、2400 cGy/6次或3000 cGy/10次。
- 不适合手术且接受常规放疗的脊髓/马尾压迫者,推荐800 cGy/1次、1600 cGy/2次、2000 cGy/5次或3000 cGy/10次。
关键数值与推荐
- 症状性骨转移常规放疗:800 cGy/1次、2000 cGy/5次、2400 cGy/6次或3000 cGy/10次(推荐)。
- 不适合手术的脊髓/马尾压迫者常规放疗:800 cGy/1次、1600 cGy/2次、2000 cGy/5次或3000 cGy/10次(推荐)。
- 选择性一般状况好、无手术或神经系统症状/体征的症状性骨转移患者:条件性推荐立体定向体部放疗优于常规姑息放疗。
- 脊柱骨转移再程常规放疗:800 cGy/1次、2000 cGy/5次、2400 cGy/6次或2000 cGy/8次(推荐)。
- 非脊柱骨转移再程常规放疗:800 cGy/1次、2000 cGy/5次或2400 cGy/6次(推荐);共享决策推荐用于以患者为中心优化治疗相关毒性和生活质量。
临床怎么用
- 脊柱转移致脊髓/马尾压迫者条件性推荐手术+术后放疗优于单纯放疗,并推荐使用地塞米松。
- 非脊柱骨转移需手术者推荐术后放疗。
- 确定最佳放疗方法/方案需整体评估,包括预后、既往放疗剂量(如适用)、正常组织风险、生活质量、费用影响及患者目标与价值观。
- 以患者为中心优化治疗相关毒性和生活质量,推荐共享决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This guideline provides evidence-based recommendations for palliative external beam radiation therapy (RT) in symptomatic bone metastases. METHODS: The ASTRO convened a task force to address 5 key questions regarding palliative RT in symptomatic bone metastases. Based on a systematic review by the Agency for Health Research and Quality, recommendations using predefined consensus-building methodology were established; evidence quality and recommendation strength were also assessed. RESULTS: For palliative RT for symptomatic bone metastases, RT is recommended for managing pain from bone metastases and spine metastases with or without spinal cord or cauda equina compression. Regarding other modalities with RT, for patients with spine metastases causing spinal cord or cauda equina compression, surgery and postoperative RT are conditionally recommended over RT alone. Furthermore, dexamethasone is recommended for spine metastases with spinal cord or cauda equina compression. Patients with nonspine bone metastases requiring surgery are recommended postoperative RT. Symptomatic bone metastases treated with conventional RT are recommended 800 cGy in 1 fraction (800 cGy/1 fx), 2000 cGy/5 fx, 2400 cGy/6 fx, or 3000 cGy/10 fx. Spinal cord or cauda equina compression in patients who are ineligible for surgery and receiving conventional RT are recommended 800 cGy/1 fx, 1600 cGy/2 fx, 2000 cGy/5 fx, or 3000 cGy/10 fx. Symptomatic bone metastases in selected patients with good performance status without surgery or neurologic symptoms/signs are conditionally recommended stereotactic body RT over conventional palliative RT. Spine bone metastases reirradiated with conventional RT are recommended 800 cGy/1 fx, 2000 cGy/5 fx, 2400 cGy/6 fx, or 2000 cGy/8 fx; nonspine bone metastases reirradiated with conventional RT are recommended 800 cGy/1 fx, 2000 cGy/5 fx, or 2400 cGy/6 fx. Determination of an optimal RT approach/regimen requires whole person assessment, including prognosis, previous RT dose if applicable, risks to normal tissues, quality of life, cost implications, and patient goals and values. Relatedly, for patient-centered optimization of treatment-related toxicities and quality of life, shared decision making is recommended. CONCLUSIONS: Based on published data, the ASTRO task force's recommendations inform best clinical practices on palliative RT for symptomatic bone metastases.
引用
- Alcorn S, Cortés ÁA, Bradfield L, et al. External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2024. PMID: 38788923. doi:10.1016/j.prro.2024.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。